GLAXOSMITHKLINE (GSK) has
confirmed it will close its Medicines
Research Unit at the Prince of
Wales Hospital in Sydney, which will
see eight full time and five contract
staff lose their jobs.
The unit would close on 30 Sep,
GSK said.
It said changes to the global
R&D landscape and so its business
model had meant the volume
of studies and type of work
channelled through the facility had
changed.
However it would continue to
conduct “globally sponsored”
clinical trials (phase one to four) in
Australia and New Zealand from its
Melbourne office, it said.
GSK Australia pharmaceuticals gm
Geoffrey McDonald said sustainable
R&D meant the company needed to
continually monitor and maximise
its return on investment.
CLICK HERE for more.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Aug 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Aug 14
PEAK pharmacy bodies are calling on the Australian Government to extend the new Commonwealth Prac Payment to pharmacy students, citing the challenges of “placement poverty” in unpaid practical placements.
AFT Pharmaceuticals is set to develop a topical treatment for keloid and hypertrophic scarring in partnership with NZ’s Massey Ventures, the commercialisation arm of Massey University, and the Gillies McIndoe Research Institute.
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.